文献速递头颈外科

头颈癌患者第三颈椎水平骨骼肌评估用于CT定义肌少症评价的有效性

The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
PubMed 文献 · Head Neck · 2022-02-09

本研究在头颈癌患者中比较第三颈椎(C3)水平骨骼肌横截面积(CSA)与第三腰椎(L3)水平CSA预测模型对肌少症诊断的一致性。共101次扫描,测量与估算CSA相关性好(r=0.86,p<0.001),但骨骼肌指数偏倚5.85%(SD=13.4%),95%一致性界限(LoA)为-20.4%至32.1%,超过临床可接受的5%限值。肌少症诊断率L3为26%、C3为45%,一致性弱(ƙ=0.368,95%CI 0.192-0.544,p<0.001),灵敏度79.2%、特异度66.7%。结论认为C3估算不能替代L3实际测量。

要点

  • C3估算与L3实测CSA相关性好(r=0.86),但骨骼肌指数偏倚5.85%超过临床可接受5%限值
  • 肌少症诊断率L3为26%、C3为45%,一致性弱(ƙ=0.368)
  • C3估算的灵敏度79.2%、特异度66.7%,存在肌少症误分类

核心结论

  • C3估算与L3实测之间一致性弱,宽泛的一致性界限、比例偏倚和肌少症误分类表明C3估算不能替代L3实际测量。

研究设计与样本

  • 研究在头颈癌患者中测量L3水平肌肉CSA,并使用预测模型通过C3水平CSA估算L3 CSA,评估一致性和肌少症诊断,共纳入101次扫描。

主要发现

  • 测量与估算CSA之间相关性好(101次扫描;r=0.86,p<0.001)。
  • CSA平均差值(偏倚)为9.99 cm2(SD=20.3 cm2)。
  • 骨骼肌指数偏倚为5.85%(SD=13.4%),95%一致性界限(LoA)为-20.4%至32.1%(r=0.29),超过临床可接受的5%限值。
  • 肌少症诊断率L3为26%、C3为45%,一致性弱(ƙ=0.368,95%CI 0.192-0.544,p<0.001),灵敏度79.2%、特异度66.7%。

关键数值与推荐

  • 测量与估算CSA相关性r=0.86(p<0.001)。
  • 骨骼肌指数偏倚5.85%(SD=13.4%),95% LoA -20.4%至32.1%,超过临床可接受的5%限值。
  • 肌少症诊断率L3为26%、C3为45%,ƙ=0.368(95%CI 0.192-0.544,p<0.001),灵敏度79.2%、特异度66.7%。

临床怎么用

  • 原文结论认为C3估算不能替代L3实际测量,未据此给出进一步临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Computed tomography (CT)-defined sarcopenia is a prognostic indicator in head and neck cancer (HNC), with the gold standard for muscle evaluation using cross-sectional area (CSA) at the third lumbar vertebra (L3). We compared methods using CSA at the third cervical vertebra (C3). METHODS: Muscle CSA was measured at L3, and CSA at C3 was used to estimate L3 CSA using a prediction model. Agreement and sarcopenia diagnosis were evaluated. RESULTS: Good correlation was found between measured and estimated CSA (101 scans; r = 0.86, p < 0.001). CSA mean difference (bias) 9.99 cm2 , (SD = 20.3 cm2 ). Skeletal muscle index bias 5.85% (SD = 13.4%), 95% limits of agreement (LoA) (-20.4 to 32.1%, r = 0.29), exceeded clinically accepted limits of 5%. Sarcopenia was diagnosed in 26%-(L3), 45%-(C3), with weak agreement (ƙ = 0.368, 95% confidence interval, 0.192-0.544, p < 0.001) (sensitivity 79.2%, specificity 66.7%). CONCLUSION: Agreement between measures was weak. Widespread LoA, proportional bias, and sarcopenia misclassification indicates that estimates using C3 cannot replace actual measures at L3.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Vangelov B, Bauer J, Moses D, et al. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer. Head Neck. 2022. PMID: 35138008. doi:10.1002/hed.27000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。